Navigation Links
WuXi PharmaTech Presents 2013 Life Science and Chemistry Awards
Date:12/10/2013

SHANGHAI, Dec. 10, 2013 /PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, announced the winners of the seventh annual WuXi PharmaTech Life Science and Chemistry Awards at a ceremony held on December 7, 2013, at Diaoyutai State Guesthouse in Beijing. Fifteen highly accomplished young scholars received the awards.

Originated in 2007, the WuXi PharmaTech Life Science and Chemistry Awards are the first nationwide scientific awards in China established by a life science enterprise. The awards aim to foster early innovation and to encourage pursuit of excellence in life science research. Participants were carefully selected by a committee comprised of distinguished experts from Chinese life science academia and industry.

"We are excited to recognize some of the brightest minds in China through our Life Science and Chemistry Awards," said Dr. Ge Li, Chairman and CEO of WuXi PharmaTech. "Their excellent research has the potential to substantially help our industry to better understand diseases and to find cures that benefit patients around the world."

Since its inception, 110 scholars from more than 30 premier Chinese universities and research institutes have received WuXi PharmaTech Life Science and Chemistry Awards, of whom three were later elected to the Chinese Academy of Sciences or the Chinese Academy of Engineering.

Winners of the 2013 Outstanding Achievements Awards included:

  • Prof. Hongkui Deng, School of Life Science, Peking University
  • Dr. Wenhui Li, National Institute of Biological Sciences, Beijing

Winners of the 2013 Scholar Awards included:

  • Prof. Wenjing Xiao, School of Chemistry, Central China Normal University
  • Dr. Yaping Li, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
  • Dr. Jinsong Li, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
  • Dr. Xuechen Li, Department of Chemistry, Hong Kong University
  • Dr. Jianjun Zhang, China Pharmaceutical University
  • Prof. Maojun Yang, School of Life Sciences, Tsinghua University
  • Dr. Jiawei Zhou, Institute of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
  • Prof. Shimin Zhao, School of Life Sciences, Fudan University
  • Dr. Niu Huang, National Institute of Biological Sciences, Beijing
  • Dr. Lijian Hui, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
  • Dr. Linghua Meng, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
  • Dr. Zhengying Pan, Shenzhen Graduate School, Peking University
  • Dr. Jianhua Ju, South China Sea Institute of Oceanology, Chinese Academy of Sciences

About WuXi PharmaTech

As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. WuXi AppTec is the name for the operating subsidiaries of WuXi PharmaTech. For more information, please visit: http://www.wuxiapptec.com.

WuXi PharmaTech's Contacts:

Ronald Aldridge, Director of Investor Relations
+1 (201) 585-2048
ron_aldridge@wuxiapptec.com

Aaron Shi, Associate Director, Corporate Communications
+86-21-5046-4362
aaron_shi@wuxiapptec.com


'/>"/>
SOURCE WuXi PharmaTech
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. WuXi PharmaTech to Partner with Pharmacyclics
2. WuXi PharmaTech Announces Third-Quarter 2013 Results
3. WuXi PharmaTech Announces Licensing Agreement for Patient-Derived Xenograft Models with Mayo Clinics Center for Individualized Medicine
4. Zacks.com featured expert Kevin Matras highlights: Core Laboratories NV, Invesco Ltd., Medtronic, Inc., Willbros Group Inc. and WuXi PharmaTech Inc.
5. WuXi PharmaTech Schedules First-Quarter 2013 Earnings Release
6. Breckenridge announces agreement with Aptalis Pharmatech to market Propranolol Hydrochloride Extended-Release Capsules
7. WuXi PharmaTech Receives Letter from AAALAC Commending Animal Care at Suzhou Toxicology Facility as "Exemplary"
8. WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2012 Results, Share Repurchase Program
9. WuXi PharmaTech and Open Monoclonal Technology Expand Human Antibody Development and Commercial Opportunities for Asian Regional and Global Pharmaceutical Companies
10. WuXi PharmaTech Schedules Fourth-Quarter 2012 Earnings Release
11. WuXi PharmaTech Presents the 2012 Life Science and Chemistry Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... 17, 2017 Research and Markets has announced the ... report to their offering. ... The report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , and Rest of World. Annual estimates and ... historic analysis is provided for these markets. Market data and analytics are ...
(Date:2/17/2017)... ST. LOUIS , Feb. 17, 2017   ... hospitals, has announced a new partnership with Engage ... the United States . FormFast will serve ... part of Engage,s implementations with MEDITECH .  ... that provides essential functionality to complement and enhance the ...
(Date:2/17/2017)... NEW YORK , Feb. 17, 2017  Noble ... coverage on ESSA Pharma Inc. (Nasdaq: EPIX ... Biotechnology Research, Kumar Raja , PhD. ... treatments for castration resistant prostate cancer (CRPC). Its lead ... selectively blocks the amino-terminal domain of the androgen receptor, ...
Breaking Medicine Technology:
(Date:2/17/2017)... Falls Church, VA (PRWEB) , ... ... ... to Integrate FDA Device Approval and Reimbursement , **An FDAnews Webinar**, Feb. ... , What are the critical reimbursement questions manufacturers should be asking ...
(Date:2/17/2017)... Seattle, WA (PRWEB) , ... February 17, 2017 ... ... health management organizations, has been named a finalist in the 8th Annual DecisionHealth ... impacting America's healthcare delivery system. Qualis Health’s work is recognized across multiple award ...
(Date:2/17/2017)... Tx (PRWEB) , ... February 17, 2017 , ... ... revenue cycle management services, announced today that Karen Pilley has been promoted to ... is critical in today’s shifting healthcare paradigm – a shift that demands the ...
(Date:2/17/2017)... ... February 17, 2017 , ... Cancer ... Molecular Medicine Tri-Conference February 20 – 22 in San Francisco. As part of ... anatomic and molecular pathology workflow solution, as well as its new precision medicine ...
(Date:2/17/2017)... ... February 17, 2017 , ... The Mason Pasquin Agency, ... and business owners in and around the Hampton Roads metropolitan region, is joining ... forms of domestic violence. , There are multiple categories of domestic violence – ...
Breaking Medicine News(10 mins):